Pulmonary Hypertension

Hoeper MM, Humbert M, Souza R et al. Aglobal view of pulmonary hypertension. Lancet Respir Med 2016; 4: 306-322.

Leber L, Beaudet A, Müller A et al. Epidemiology of pulmonary arteriel hypertension and chronic thromboembolic pulmonary hypertension identification of the most accurate estimates from a systematic literature review. Pulm Circ 2021; 11: 2045894020977300.

Lau EMT, Giannoulalou E, Celermajer DS et al. Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol 2017; 14: 603-614.

Coghian JG, Denton CP, Grunig E et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis the DETECT study. Ann Rheum Dis 2014; 73: 1340-1349.

Gaile N, Humbert M, Vachiery JL et al. 2015 ESC/ERS Guidelines fort he diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903-975.

Bahi M, Li C, Wang G et al. Systemic sclerosis associated pulmonary arterial hypertension: from bedside to bench and back again. International Journal of Molecular Sciences.2024, 25, 4728.

Humbert M, Kovacs G, Hoeper MM et al. 2022 ESC/ERS Guidelines fort he diagnosis and treatment of pulmonary hypertension. European Heart Journal (2022) 43, 3618-3731.

Montani D, Girerd B, Jais X et al. Screening for pulmonary arteriel hypertension in adults carrying a BMPR2 mutation. The Eur Respir J 2020; 58: 2004229.

Kovacs G, Avian A, Foris V et al. Use of ECG and other simple noninvasive tools to Access pulmonary hypertension. PLoS One 2016: 11: e0168706.

Sun XG, Hansen JE, Oudiz RJ et al. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol 2003; 41: 1028-1035.

Rudski LG, Lai WW, Afilalo J et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.

Galderisi M, Cosyns B, Edvardsen T et al. Standardization of adult transthoracic echocardiography reporting in aggrement with recent chamber quantification, diastolic function and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2017; 18: 1301-1310.

Swift AJ, Dwivedi K, Johns C et al. Diagnosis accuracy of CT pulmonary angiography in suspected pulmonary hypertension. Eur Radiol 2020: 30; 4918-4929.

Dong C, Zhou M, Liu D et al. Diagnosis accuracy of computed tomography for chronic thromboembolic pulmonary hypertension; a systematic review and meta- analysis. PLoS One 2015; 10e0126985.

Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017; 377: 2298.

Mehra MR, Canter CE, Hannan MM et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10 year update. J Heart Lung Transplant 2016: 35; 1-23.

Opotowsky AR, Hess E, Maron BA et al. Thermodilution vs estimated Fick cardiac output measurement in clinical practice: an analysis of mortality from the Veterans Affairs Clinical Assessment, Reporting and Tracking Program and Vanderbilt University. JAMA Cardiol 2017; 2: 1090-1099.

Sitbon O, Humbert M, Jais X et al. Long term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005: 111: 3105-3111.

Savarese G, Paolillo S, Costanzo P et al. Do changes of 6 minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A Meta- analysis of 22 randomized trials. J Am Call Cardiol 2012; 60: 1192-1201.

Zeiniker TA, Huscher D, Vonk- Noordegraaf A et al. The 6MWT as a prognostic tool in pulmonary arterial hypertension results from the COMPERA registry. Clin Res Cardiol 2018; 107: 460-470.

Hoeper MM, Kramer T, Pan Z et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 2017; 50: 1700740.

Rubin LJ, Badesch DB, Barst RJ et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903.

Galie N, Olschewski H, Oudiz RJ et al. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 2008; 117: 3010-3019.

Galie N, Ghofrani HA, Torbicki A et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353: 2148-2157.

Sitbon O, Deicroix M, Bergot E et al. EPITOME- 2: An open label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension. Am Heart J 2014; 167: 210-217.

Tuhy T, Hassoun P.M. Clinical features of pulmonary arterial hypertension associated with systemic sclerosis. Front. Med. 2023, 10, 1264906.

Badesch DB, Raskob GE, Elliott CG et al. Pulmonary arterail hypertension, baseline characteristics from the REVEAL Registry Chest 2010; 137: 376-87.

Avouac J, Airo P, Meune C et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J. Rheumatol, 2010, 37, 2290-2298.

29.Launay D, Sobanski V, Hachulla E et al. Pulmonary hypertension in systemic sclerosis: different phenotypes. Eur Respir Rev 2017; 26: 170056.

Lambova S. Cardiac manifestations in systemic sclerosis. World J Cardiol 2014; 6: 993-1005.

Dorfmuller P, Montani D, Humbert M. Beyond arterial remodelling: Pulmonary venous and cardiac involvement in patients with systemic sclerosis associated pulmonary arterial hypertension. Eur. Respir. J. 2010, 35, 6-8.

Overbeek MJ, Vonk MC, Boonstra A et al. Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: A distinctive vasculopathy. Eur. Respir. J. 2009, 34, 371-379.

Khanna D, Gladue H, Channick R et al. Recommendations for screening and detection of connective tissue disease associated pulmonary arterial hypertension. Arthritis Rheum 2013; 65: 3194-201.

Hannah JR, D’Cruz DP. Pulmonary complications of systemic lupus erythematosus. Semin. Respir. Crit. Care Med. 2019, 40,227-234.

Aguilera Pickens G, Abud Mendoza C. Pulmonary manifestations in systemic lupus erythematosus: Pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage. Reumatol. Clin. 2018, 14, 294-300.

Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus: Current status and future direction. Clin. Dev. Immunol. 2012, 2012, 854941.

Dawson JK, Goodson NG, Graham DR et al. Raised pulmonary artery pressures measured with doppler echocardiography in rheumatoid arthritis patients. Rheumatology 39 (12) (2000) 1320-1325.

Panagiotidou E, Sourla E, Kotoulas SX et al. Rheumatoid arthritis associated pulmonary hypertension: Clinical challenges reflecting the diversity of pathophysiology. Respiratory Medicine Case Reports 20 (2017) 164-167.

Misita CP, Moll S. Antiphospholipid antibodies. Circulation. 2005; 112: e39-e 44.

Ford HJ, Roubey RA. Pulmonary manifestations of the antiphospholipid antibody syndrome. Clin Chest Med. 2010; 31: 537-545.

Tacoy G, Abacı A, Onal B et al. A rare cause of pulmonary hypertension: bilateral pulmonary artery involvement and stent restenosis due to Takayasu arteritis. Arch Turk Soc Cardiol 2014; 42(4): 389-394.

Salvarani C, Cantini F, Boiardi L et al. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 2002; 347: 261-271.

Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002; 287: 92-101.

Liu J, Liu Y, Shen X et al. Clinicopathological characteristics of Ig G4- related lung disease. BMC Pulmonary Medicine (2021) 21: 21; 413.

Simonneau G, Gatzoulis MA, Adatia I et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013; 62(25 suppl):D34-D41.

Palmer SM, Robinson LJ, Wang A et al. Massive pulmonary edema and deatht after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest. 1998; 113: 237-240.

Fayed H, Coghlan JG. Pulmonary hypertension associated with connective tissue disease. Semin Respir Crit Care Med 2019; 40: 173-183.